Publications by authors named "Nadyr P Damasceno"

2 Publications

  • Page 1 of 1

Treatment of Radiation Retinopathy with Intravitreal Injection of Ranibizumab (Lucentis).

Int Med Case Rep J 2020 11;13:27-32. Epub 2020 Feb 11.

Department of Ophthalmology, Universidade Federal Fluminense, Niteroi, Brazil.

To report a treatment of radiation retinopathy in a patient exposed to ionizing radiation for a period of 2 years. A 26-year-old female patient with no comorbidities diagnosed with myelodysplasia confirmed by bone marrow biopsy. She presented a complaint of bilateral progressive visual acuity reduction. At the ophthalmologic examination, she presented alterations suggestive of radiation retinopathy as well as macular thickness to optical coherence tomography (OCT) of over 500 ┬Ám. The patient underwent intravitreal injection (0.05 mL) of ranibizumab (Lucentis) monthly in both eyes and follow-up through visual acuity and OCT examination. She presented reduction of macular edema as well as a slight improvement of visual acuity. In this case, the treatment of radiation retinopathy with intravitreal injection of ranibizumab (Lucentis) was relatively useful, with a slight improvement of visual acuity, due to the regression of macular edema, not being curative.
View Article and Find Full Text PDF

Download full-text PDF

Source Listing
February 2020

Leuconostoc as a Cause of Endophthalmitis Post-intravitreal Injection of Ranibizumab.

Ocul Immunol Inflamm 2016 21;24(1):118-9. Epub 2014 Apr 21.

b Department of Ophthalmology School of Medicine - Universidade Federal Fluminense , Niteroi , Brazil.

Purpose: The authors report a case of endophthalmitis after intravitreal injection of ranibizumab.

Methods: After searching for extensive laboratory tests to isolate the etiologic agent Results: The agent was determined as Leuconostoc mesenteroides, gram-positive cocci, vancomycin resistant.

Discussion: Considerations regarding this bacterium were done by calling attention to its rarity, difficulty of isolation, and action on secondary comorbidities as opportunistic pathogen.
View Article and Find Full Text PDF

Download full-text PDF

Source Listing
November 2016